Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.

Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This indicates a minor software update and does not modify the study details or visible content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision updated from v3.6.3 to v3.6.4, representing a minor version update to the page rather than a substantive content change.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision marker was updated from v3.6.2 to v3.6.3, indicating a minor update to the page version.SummaryDifference0.1%

- Check57 days agoChange DetectedThe revision indicator on the page updates to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check72 days agoChange DetectedA recruitment-status update was added stating that the study is no longer recruiting participants. This clarifies that enrollment has completed and informs readers about current availability.SummaryDifference0.4%

- Check79 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, indicating a new revision of the study record.SummaryDifference0.1%

Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.